EBF2 and fatty liver disease: Adipose-specific Blnc1 transgenic expression alleviated diet-induced systemic IR and hepatic steatosis by suppressing BAT whitening and eWAT inflammation through several targets including EBF2, hnRNPU, Zbtb7b, hnRNPA1 and PGC-1β